© 2024 Myocardial Solutions Inc. All rights reserved.
MORRISVILLE, N.C., March 23, 2022 – Myocardial Solutions, Inc. (MSI) announces opening of first MyoStrain Cardiac Prevention Center in conjunction with Nuestra Señora del Rosario in Madrid, Spain.
The hospital has initiated an online “direct to patient” program to inform patients with chronic diseases, or long COVID that MyoStrain® can provide an accurate, cardiac function assessment of the effects of disease on the heart.
Access to the formal hospital announcement is available here.
Additional information about MyoStrain and the program is available here.
A video of Dr. Vañó, who heads the MyoStrain Prevention Program, explaining the role and benefit of MyoStrain within his program can be viewed here.
PR@myocardialsolutions.com
919.677.8100
Myocardial Solutions, Inc. (MSI) is a medical technology company working to transform the cardiac and cancer care continuum. Leveraging more than 400 publications in clinical research and development, MSI’s proprietary technology, MyoStrain®, is a 10-minute, MRI-based heart function test providing physicians with sensitive diagnostic markers to support the early assessment and individualized treatment of heart dysfunction. MyoStrain has received FDA-510(k) pre-market clearance, CE-mark certification, and is commercially available in the United States and Europe.
To learn more about MyoStrain, visit myocardialsolutions.com or connect with us on LinkedIn and Twitter @myocardialsoln.
808 Aviation Pkwy, Suite 700 | Morrisville, NC 27560 | myocardialsolutions.com | ph: +1.919.677.8100
© Copyright 2022 Myocardial Solutions Inc. All rights reserved. MyoStrain® and the MyoHealthTM
Score are among the trademarks of Myocardial Solutions.
